Expression of the c-myc oncogene and the presence of HPV 18: possible surrogate markers for cervical cancer?

References

• Rughooputh S, Kachaliya S, Jetly D, Greenwell P. Cervical cancer and human papillomavirus among slum dwellers in India. Br J Biomed Sci 2007; 64: 28–31.
   Google Scholar
• Brake T, Lambert PF. Estrogen contributes to the onset, persistence and malignant progression of cervical cancer in a human papillomavirus–transgenic mouse model. Proc Natl Acad Sci USA 2005; 102: 2490–5.
   Google Scholar
• Rughooputh S, Eddoo R, Manraj S, Jeebun N, Greenwell P. Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius. J Clin Virol 2006; 35: 173–8.
   Google Scholar
• Deerasamee S, Srivatanakul P, Sriplung H et al. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand. Asian Pac J Cancer Prev 2007; 8: 547–56.
   Google Scholar
• Diaz M, Kim JJ, Albero G et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer 2008; 99: 230–8.
   Google Scholar
• Ordóñez RM, Espinosa AM, Sánchez-González DJ, Armendáriz-Borunda J, Berumen J. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol 2004; 85: 1433–44.
   Google Scholar
• Cutts FT, Franceschi S, Goldie S et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 2007; 85: 719–26.
   Google Scholar
• Simon P, Poppe W. Should the anti-papillomavirus vaccination after the age of 25 be advised? (in French). J Gynecol Obstet Biol Reprod (Paris) 2008; 37 (8): 748–52.
   Google Scholar
• Clifford GM, Gallus S, Herrero R et al. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005; 366: 991–8.
   Google Scholar
• Heilmann V, Kreienberg R. Molecular biology of cervical cancer and its precursors. Curr Womens Health Rep 2002; 2: 27–33.
   Google Scholar
• Brenna SMF, Zeferino LC, Pinto GA et al. C-myc protein expression is not an independent prognostic predicator in cervical squamous cell carcinoma. Braz J Med Biol Res 2002; 35: 425–30.
   Google Scholar
• Peitsaro P, Hietanen S, Johansson B, Lakkala T, Syrjanen S. Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis 2002; 23: 1057–64.
   Google Scholar
• Enomoto T, Inoue M, Perantoni AO, Terakawa N, Tanizawa O, Rice JM. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 1990; 50: 6139–45.
   Google Scholar
• Rughooputh S. The role of sexually transmitted organisms in the pathogenesis of cervical cancer. PhD thesis. 2003. University of Westminster, UK.
   Google Scholar
• Ting Y, Manos M. Detection and typing of genital human papillomaviruses. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ eds. PCR protocols: a guide to methods and applications. New York: Academic Press, 1990: 356–7.
   Google Scholar
• Vijayalakshmi N, Selvaluxmi G, Mahji U, Rajkumar T. C-myc oncoprotein expression and prognosis in patients with carcinoma of the cervix: an immunohistochemical study. Eur J Gynaecol Oncol 2002; 23: 135–8.
   Google Scholar
• Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403–10.
   Google Scholar
• Ngan HY, Cheung AN, Liu SS, Cheng DK, Ng TY, Wong LC. Abnormal expression of pan-ras, C-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis. Oncol Rep 2001; 8: 557–61.
   Google Scholar
• Kersemaekers AM, Fleuren GJ, Kenter GG et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 1999; 5: 577–86.
   Google Scholar
• Aoyama C, Peters J, Senadheera S, Liu P, Shimada H. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction. Diagn Mol Pathol 1998; 7: 324–30.
   Google Scholar
• Nair SA, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR. ras and c-myc oncoproteins during tumor progression in the uterine cervix. Tumori 1998; 84: 583–8.
   Google Scholar
• Zhang A, Maner S, Betz R et al. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer 2002; 101: 427–33.
   Google Scholar
• Manraj SS, Mustun H, Ghurburrun P, Laniece C, Salamon R. Cancer incidence in Mauritius (1989–1993) (in French). Rev Epidemiol Sante Publique 1997; 45: 257–9.
   Google Scholar
• Manraj SS, Mustun H, Ghurburrun P, Laniece C, Salamon R. Cancer incidence in Mauritius (1989–1993) (in French). Bull Soc Pathol Exot 1998; 91: 9–12.
   Google Scholar
• Karaloglu D, Yazici H, Alatli C et al. Detection of HPV 16 and HPV 18 infection in patients with cervical neoplasia. Eur J Gynaecol Oncol 1996; 17: 296–8.
   Google Scholar
• Schneider-Gadicke A, Schwartz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986; 5: 2285–92.
   Google Scholar
• Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B. Modification of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 1994; 4: 604–11.
   Google Scholar
• Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 1985; 119: 361–6.
   Google Scholar
• Brewer CA, Liao SY, Wilczynski SP et al. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. Gynecol Oncol 1996; 63: 337–44.
   Google Scholar
• Sepp R, Szabo I, Uda H, Sakamoto H. Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 1994; 47: 318–23.
   Google Scholar
• Frank TS, Svoboda-Newman SM, Hsi ED. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for non-isotopic PCR. Diagn Mol Pathol 1996; 5: 220–4.
   Google Scholar
• de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057.
   Google Scholar
• Tieben LM, Schegget J, Minnaar RP et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 1993; 42: 265.
   Google Scholar
• Rolighed J, Bichel P, Lindeberg H. The presence of HPV in cervical biopsies, determined by histology and PCR with 2 different pairs of consensus primers. Eur J Gynaecol Oncol 1997; 18: 365–7.
   Google Scholar
• Unger ER, Vernon SD, Lee DR, Miller DL, Reeves WC. Detection of human papillomavirus in archival tissues: comparison of in situ hybridisation and polymerase chain reaction. J Histochem Cytochem 1998; 46: 535–40.
   Google Scholar
• Shibata D, Martin WJ, Arnheim N. Analysis of DNA sequences in forty-year-old paraffin-embedded thin tissue sections: a bridge between molecular biology and classical histology. Cancer Res 1988; 48: 4564–6.
   Google Scholar
• Iwamoto KS, Mizuno T, Ito T et al. Feasibility of using decadesold archival tissues in molecular oncology/epidemiology. Am J Pathol 1996; 149: 399–406.
   Google Scholar
• Munoz N, Xavier Bosch F, De Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518–27.
   Google Scholar
• Harington J. Epidemiology and aetiology of cancer of the uterine cervix, including the detection of carcinogenic N-nitrosamines in the human vaginal vault. S Afr Med J 1975; 49 (12): 443–5.
   Google Scholar